Dysregulated serum levels of human tissue kallikreins, hK7 and hK10, as potential biomarkers of asthma
Open Access
- 10 May 2026
- journal article
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 46, 102621
Abstract
No abstract availableKeywords
Funding Information
- Higher Education Commission, Pakistan
This publication has 33 references indexed in Scilit:
- Genome-wide association study identifies kallikrein 5 in type 2 inflammation-low asthmaJournal of Allergy and Clinical Immunology, 2022
- Why do some asthma patients respond poorly to glucocorticoid therapy?Pharmacological Research, 2020
- Fine particulate matter increases airway hyperresponsiveness through kallikrein-bradykinin pathwayEcotoxicology and Environmental Safety, 2020
- Physiological and pathological roles of kallikrein-related peptidases in the epidermisJournal of Dermatological Science, 2019
- Bradykinin in asthma: Modulation of airway inflammation and remodellingEuropean Journal of Pharmacology, 2018
- Down-regulation of hK7 in the sera of breast cancer and benign breast disease patientsHeliyon, 2017
- Glucocorticosteroids2016
- TH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitisJournal of Allergy and Clinical Immunology, 2012
- Asthma outcomes: BiomarkersJournal of Allergy and Clinical Immunology, 2012
- KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancerBiochemical and Biophysical Research Communications, 2005